EMV Capital
Venture capitalLondon · Pre-Seed–Series B · 20 people tracked
Also known as Greybridge It Limited · Netscientific Limited · Netscientific Plc
Investment thesis
EMV Capital focuses on generating strong investor returns by investing in early-stage companies operating in fast-growing sectors and technologies expected to shape the future. It targets businesses with attractive intellectual property and both high growth and impact potential. The firm applies a proactive, hands-on management style, working closely with companies over an extended period to advance them toward key value inflection points. Its capital-efficient model draws on its own balance sheet and syndicate investments. EMV concentrates on three areas: life sciences addressing healthcare system challenges, deeptech spanning industrials, robotics and AI, and sustainability including renewable energy, resource efficiency, waste reduction and sustainable supply chains.
Source: firm website, verified Aug 3, 2026.
Team · 20 people
from the firm's website
What they invest in
from 8 of 61 portfolio companiesBiotech ×5Healthtech ×4AI & Machine Learning ×3Medical Devices ×3Deep Tech ×1Digital Health ×1Hardware ×1IoT ×1
HQs:United States×5United Kingdom×3
Investments · 61 tracked
founders shown can be your intro pathNASDAQ-listed company harnessing immunology for therapeutic development
BiotechNorth Brunswick, US
Frank K. Bedu-Addo(Executive Officer)
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)Jack Fuchs(Director, Promoter)in
BoardLindy Fishburne(Director)
AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
AI & Machine LearningBiotech
Genetic testing platform for complex diagnostic workflows from patient sampling to result
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical Devices<UNKNOWN>, US
Nina Tandon(Co-Founder, CEO)Sarindr Bhumiratana(Co-Founder)Robert Langer(Director)Gordana Vunjak-Novakovic(Director)David Zhu(Director)Elma Hawkins(Director)
Medical technology company developing diagnostics for Functional Gastrointestinal Disorders
Mountain View, US
Steve Axelrod(Executive Officer, Director, Promoter)David Kim(Director)
Liver disease diagnostics company commercializing blood tests for life-threatening liver cancers
HealthtechMerion Station, US
Charles Swindell(Executive Officer, Director)Jenny Jiang(Director)
BoardIlian Iliev(Director)Ed Hooper(Director)
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
AI & Machine LearningBiotechHealthtechMedical DevicesOxford, GB
Jonathan Kwok(Co-Founder, President & Chief Medical Officer)Lian Ni Lee(VP Preclinical & Co-Founder)
Nu Quantum develops quantum networking solutions to enable commercial quantum computer scaling.
Deep TechHardwareQuantum ComputingCambridge, GB
Dr. Carmen Palacios-Berraquero(Founder and CEO)
Targeted radiopharmaceutical cancer treatment company
Commercial medtech company with focus on respiratory diagnostics
Brain and neurological disease diagnosis company
Medical technology company founded to address global climate crisis through healthcare innovation
Benchtop solution for label-free, sample preparation-free isolation and purification
Intelligent platform for Remote Patient Monitoring and Virtual Care
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2025
Director · British · since 2022
Director · British · since 2019
Director · British · since 2022
Director · British · since 2023
Frequently asked questions
- What stage does EMV Capital invest at?
- EMV Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does EMV Capital focus on?
- EMV Capital focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Healthtech, Impact & Social Good, Robotics, Semiconductors.
- Where is EMV Capital located?
- EMV Capital is headquartered in London, GB.
- Does EMV Capital lead rounds?
- Yes, EMV Capital leads investment rounds.
Images
Similar investors
Simsan Ventures is an early-stage venture firm focused on democratising access to capital for overlooked and underrepresented founders, investing across Europe, India and South Korea.
Supernova Invest is a venture capital firm providing expertise and patient capital to high-growth deeptech start-ups, helping scale them globally.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.